Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 998,170 | 889,219 | 1,223,680 | 857,000 | 812,570 |
| Cost of Goods | 276,770 | 241,340 | 332,290 | 225,000 | 208,690 |
| Gross Profit | 721,390 | 637,920 | 891,390 | 632,000 | 603,880 |
| Operating Expenses | 509,030 | 470,200 | 667,240 | 431,000 | 426,130 |
| Operating Income | 213,140 | 178,019 | 224,440 | 201,000 | 178,440 |
| Other Income | 84,900 | 60,011 | 97,750 | 4,000 | 30,870 |
| Pre-tax Income | 298,040 | 238,030 | 322,190 | 205,000 | 209,310 |
| Income Tax | N/A | N/A | 164,720 | 72,000 | 73,280 |
| Net Income Continuous | 196,750 | 158,850 | 209,250 | 133,000 | 136,520 |
| Net Income | $196,750 | $158,850 | $209,250 | $133,000 | $136,520 |
| EPS Basic Total Ops | N/A | 0.02 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | N/A | 0.02 | N/A | N/A | N/A |
| EPS Diluted Total Ops | N/A | 0.02 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | 0.02 | N/A | N/A | N/A |
| EBITDA(a) | $213,140 | $178,019 | $224,440 | $201,000 | $178,440 |